SEC Filing Summary: Oculus Innovative Sciences, Inc.
Business Context and Reporting Period
This Form 8-K Current Report was filed by Oculus Innovative Sciences, Inc. on January 16, 2008. The filing reports a corporate governance event effective as of the report date. Note: The request metadata references "Sonoma Pharmaceuticals, Inc.," but the filing text explicitly identifies the registrant as Oculus Innovative Sciences, Inc.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial statements or operational metrics.
Material Changes
The primary material change reported is the appointment of a new director:
- Gregg H. Alton was elected to serve as a member of the Board of Directors.
- Mr. Alton was designated as an independent director.
- He was appointed to serve on the Audit Committee of the Board.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future guidance, outlook, risks, contingencies, or unusual items. The disclosure is limited to the announcement of the board election and the inclusion of a press release as Exhibit 99.1.
Investor Verification Checklist
- Verify the background and qualifications of the newly appointed independent director, Gregg H. Alton.
- Review the attached press release (Exhibit 99.1) for additional context on the board's strategic direction.
- Confirm the current composition of the Audit Committee following Mr. Alton's appointment.